SurGraft® is a state-of-the-art single layer allograft derived from amnion. It serves as a protective barrier, and ensuring optimal protection.
SurGraft® is processed in compliance with the United States Food and Drug Administration current Good Tissue Practices (cGTP) Regulations and the American Association of Tissue Banks Standards. We pride ourselves on quality and testing that meet or exceed industry standards.
SurGraft® has been shown to be effective as a protective covering in the management of chronic non-healing ulcers including diabetic, pressure, and venous ulcers. Our allografts support enhanced tissue adherence along with heightened strength and effortless handling.
SurGraft® is regulated under Section 361 of the PHS Act and FDA 21 CFR Part 1271 and is intended for homologous use.
HCPCS Level II Code Q4209, "SurGraft, per square centimeter"
Large Format Sizes
Surgenex® is proud to introduce large format sheet sizes tailored to providers’ needs.
Fresh Tissue Processing
Tissue is collected promptly and delivered fresh for processing to achieve optimal results.
No Harsh Chemicals or Antibiotics
Our proprietary Excellion® process focuses on harnessing the natural benefits of the tissue with minimal manipulation.
Meticulous Quality Assurance
Surgenex® takes pride in assuring the highest technical quality and rigorous testing to ensure safety without compromise.
